US Stock MarketDetailed Quotes

IMMX Immix Biopharma

Watchlist
  • 2.150
  • +0.090+4.37%
Close Jul 25 16:00 ET
  • 2.020
  • -0.130-6.05%
Post 20:01 ET
56.79MMarket Cap-2311P/E (TTM)

Immix Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
121.76%5.59M
96.39%16.14M
41.67%5.38M
195.02%4.52M
138.36%3.72M
89.52%2.52M
507.90%8.22M
534.19%3.79M
340.64%1.53M
541.93%1.56M
Selling and administrative expenses
94.84%2.34M
84.09%7.41M
48.50%2.28M
188.71%2.42M
58.57%1.51M
71.55%1.2M
228.29%4.02M
160.06%1.53M
163.10%837.44K
428.37%953.2K
-General and administrative expense
94.84%2.34M
84.09%7.41M
48.50%2.28M
188.71%2.42M
58.57%1.51M
71.55%1.2M
228.29%4.02M
160.06%1.53M
163.10%837.44K
428.37%953.2K
Research and development costs
146.29%3.25M
108.19%8.74M
37.05%3.1M
202.62%2.11M
263.51%2.21M
109.52%1.32M
3,216.11%4.2M
24,397.17%2.26M
2,244.01%695.94K
868.36%607.75K
Operating profit
-121.76%-5.59M
-96.39%-16.14M
-41.67%-5.38M
-195.02%-4.52M
-138.36%-3.72M
-89.52%-2.52M
-507.90%-8.22M
-534.19%-3.79M
-340.64%-1.53M
-541.93%-1.56M
Net non-operating interest income expense
860.52%267.91K
115,191.75%572.01K
228.58K
186.69K
118,309.17%128.85K
7,288.66%27.89K
99.72%-497
0
0
99.80%-109
Non-operating interest income
860.52%267.91K
--572.01K
--228.58K
--186.69K
--128.85K
--27.89K
--0
--0
--0
--0
Non-operating interest expense
----
--0
--0
--0
--0
----
-99.72%497
--0
--0
-99.80%109
Other net income (expense)
Income before tax
-113.50%-5.32M
-89.42%-15.57M
-35.65%-5.15M
-182.85%-4.34M
-130.09%-3.59M
-87.37%-2.49M
66.28%-8.22M
83.32%-3.79M
-281.51%-1.53M
-654.03%-1.56M
Income tax
70.97%8.84K
157.26%26.42K
53.81%8.09K
307.12%6.81K
270.20%6.35K
218.74%5.17K
70.76%10.27K
256.06%5.26K
25.06%1.67K
6.65%1.72K
Net income
-113.41%-5.33M
-89.50%-15.6M
-35.67%-5.16M
-182.98%-4.34M
-130.24%-3.6M
-87.53%-2.5M
66.25%-8.23M
83.30%-3.8M
-280.66%-1.54M
-649.04%-1.56M
Net income continuous Operations
-113.41%-5.33M
-89.50%-15.6M
-35.67%-5.16M
-182.98%-4.34M
-130.24%-3.6M
-87.53%-2.5M
66.25%-8.23M
83.30%-3.8M
-280.66%-1.54M
-649.04%-1.56M
Minority interest income
-292.38%-72.07K
-169.47K
-65.86K
-63.25K
-22K
-18.37K
0
0
0
0
Net income attributable to the parent company
-112.08%-5.26M
-87.44%-15.43M
-33.94%-5.09M
-178.86%-4.28M
-128.84%-3.58M
-86.15%-2.48M
66.25%-8.23M
83.30%-3.8M
-280.66%-1.54M
-649.04%-1.56M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-112.08%-5.26M
-87.44%-15.43M
-33.94%-5.09M
-178.86%-4.28M
-128.84%-3.58M
-86.15%-2.48M
66.25%-8.23M
83.30%-3.8M
-280.66%-1.54M
-649.04%-1.56M
Basic earnings per share
-22.22%-0.22
-50.85%-0.89
11.11%-0.24
-109.09%-0.23
-118.18%-0.24
-80.00%-0.18
91.11%-0.59
84.30%-0.27
-96.40%-0.11
-362.63%-0.11
Diluted earnings per share
-22.22%-0.22
-50.85%-0.89
11.11%-0.24
-109.09%-0.23
-118.18%-0.24
-80.00%-0.18
91.11%-0.59
84.30%-0.27
-96.40%-0.11
-362.63%-0.11
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 121.76%5.59M96.39%16.14M41.67%5.38M195.02%4.52M138.36%3.72M89.52%2.52M507.90%8.22M534.19%3.79M340.64%1.53M541.93%1.56M
Selling and administrative expenses 94.84%2.34M84.09%7.41M48.50%2.28M188.71%2.42M58.57%1.51M71.55%1.2M228.29%4.02M160.06%1.53M163.10%837.44K428.37%953.2K
-General and administrative expense 94.84%2.34M84.09%7.41M48.50%2.28M188.71%2.42M58.57%1.51M71.55%1.2M228.29%4.02M160.06%1.53M163.10%837.44K428.37%953.2K
Research and development costs 146.29%3.25M108.19%8.74M37.05%3.1M202.62%2.11M263.51%2.21M109.52%1.32M3,216.11%4.2M24,397.17%2.26M2,244.01%695.94K868.36%607.75K
Operating profit -121.76%-5.59M-96.39%-16.14M-41.67%-5.38M-195.02%-4.52M-138.36%-3.72M-89.52%-2.52M-507.90%-8.22M-534.19%-3.79M-340.64%-1.53M-541.93%-1.56M
Net non-operating interest income expense 860.52%267.91K115,191.75%572.01K228.58K186.69K118,309.17%128.85K7,288.66%27.89K99.72%-4970099.80%-109
Non-operating interest income 860.52%267.91K--572.01K--228.58K--186.69K--128.85K--27.89K--0--0--0--0
Non-operating interest expense ------0--0--0--0-----99.72%497--0--0-99.80%109
Other net income (expense)
Income before tax -113.50%-5.32M-89.42%-15.57M-35.65%-5.15M-182.85%-4.34M-130.09%-3.59M-87.37%-2.49M66.28%-8.22M83.32%-3.79M-281.51%-1.53M-654.03%-1.56M
Income tax 70.97%8.84K157.26%26.42K53.81%8.09K307.12%6.81K270.20%6.35K218.74%5.17K70.76%10.27K256.06%5.26K25.06%1.67K6.65%1.72K
Net income -113.41%-5.33M-89.50%-15.6M-35.67%-5.16M-182.98%-4.34M-130.24%-3.6M-87.53%-2.5M66.25%-8.23M83.30%-3.8M-280.66%-1.54M-649.04%-1.56M
Net income continuous Operations -113.41%-5.33M-89.50%-15.6M-35.67%-5.16M-182.98%-4.34M-130.24%-3.6M-87.53%-2.5M66.25%-8.23M83.30%-3.8M-280.66%-1.54M-649.04%-1.56M
Minority interest income -292.38%-72.07K-169.47K-65.86K-63.25K-22K-18.37K0000
Net income attributable to the parent company -112.08%-5.26M-87.44%-15.43M-33.94%-5.09M-178.86%-4.28M-128.84%-3.58M-86.15%-2.48M66.25%-8.23M83.30%-3.8M-280.66%-1.54M-649.04%-1.56M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -112.08%-5.26M-87.44%-15.43M-33.94%-5.09M-178.86%-4.28M-128.84%-3.58M-86.15%-2.48M66.25%-8.23M83.30%-3.8M-280.66%-1.54M-649.04%-1.56M
Basic earnings per share -22.22%-0.22-50.85%-0.8911.11%-0.24-109.09%-0.23-118.18%-0.24-80.00%-0.1891.11%-0.5984.30%-0.27-96.40%-0.11-362.63%-0.11
Diluted earnings per share -22.22%-0.22-50.85%-0.8911.11%-0.24-109.09%-0.23-118.18%-0.24-80.00%-0.1891.11%-0.5984.30%-0.27-96.40%-0.11-362.63%-0.11
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg